Trial Profile
A prospective, multi-center study assessing efficacy of multiple overlapping Everolimus-eluting stents in patients with diffuse long coronary artery disease : XILLION (XIence/promus for Long coronary LesION) registry trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 27 Dec 2015 New trial record